Patent intelligence · US
US 8426611
7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof
7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof
Patent details — US 8426611
- Jurisdiction
- US
- Status
- granted
- Grant date
- Apr 23, 2013
- Expiration
- Apr 18, 2033
- Applicant
- THERON PHARMACEUTICALS, INC.
- Claims
- 23
- CPC classes
- A61K, A61K31/407, A61K31/4188, A61K45/06
Quick answer
US 8426611 (7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof) is held by THERON PHARMACEUTICALS, INC.. Status: granted. Granted Apr 23, 2013. Expires Apr 18, 2033 (7 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- THERON PHARMACEUTICALS, INC.
- Grant date
- Expiration
- Claims
- 23
- CPC classes
- A61K, A61K31/407, A61K31/4188, A61K45/06, A61K9/0078, A61P
More from THERON PHARMACEUTICALS, INC.
Related pharmaceutical patents in our USPTO index.
-
US 12318376
Compositions of a polyorthoester and an aprotic solvent
granted -
US 12290520
Methods of use of emulsion formulations of aprepitant
granted -
US 12115254
Methods of use of emulsion formulations of an NK-1 receptor antagonist
granted -
US 12115255
Methods of use of emulsion formulations of an NK-1 receptor antagonist
granted -
US 11878074
Methods of use of emulsion formulations of an NK-1 receptor antagonist
granted -
US 11844837
Compositions of a polyorthoester and an organic acid excipient
granted -
US 11744800
Methods of use of emulsion formulations of an NK-1 receptor antagonist
granted -
US 11413350
Long-acting polymeric delivery systems
granted
Frequently asked questions
What is US patent 8426611?
US 8426611 (7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof) is held by THERON PHARMACEUTICALS, INC.. Status: granted. Granted Apr 23, 2013. Expires Apr 18, 2033 (7 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8426611?
THERON PHARMACEUTICALS, INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 46 pharmaceutical patents for this assignee.
When does US 8426611 expire?
Our index shows an expiration date of Apr 18, 2033 (7 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.